Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial
- Resource Type
- Article
- Authors
- Zhou, Caicun; Huang, Dingzhi; Fan, Yun; Yu, Xinmin; Liu, Yunpeng; Shu, Yongqian; Ma, Zhiyong; Wang, Ziping; Cheng, Ying; Wang, Jie; Hu, Sheng; Liu, Zhihua; Poddubskaya, Elena; Disel, Umut; Akopov, Andrey; Dvorkin, Mikhail; Zheng, Wenjuan; Ma, Yiyuan; Wang, Yan; Li, Songzi; Yu, Cunjing; Rivalland, Gareth
- Source
- In Journal of Thoracic Oncology January 2023 18(1):93-105
- Subject
- Language
- ISSN
- 1556-0864